Clinical trials
Completed Phase 2 Essential Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boryung Pharmaceutical Co., Ltd | 3 |
| Novartis Pharmaceuticals | 3 |
| Addpharma Inc. | 2 |
| Idorsia Pharmaceuticals Ltd. | 2 |
| Shin Poong Pharmaceutical Co. Ltd. | 2 |
| Ablative Solutions, Inc. | 1 |
| Bayer | 1 |
| Chong Kun Dang Pharmaceutical | 1 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essential Hypertension | 32 |
| Hypertension | 10 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Diabetic Nephropathies | 1 |
| Heart Failure | 1 |
| Hypertrophy, Left Ventricular | 1 |
| Vascular Diseases | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.